AQR Capital Management
ROIV icon

AQR Capital Management’s Roivant Sciences ROIV Stock Holding History

AQR Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162M Buy
5,946,858
+5,066,085
+575% +$130M 0.07% 355
2025
Q4 		$19M Buy
880,773
+810,402
+1,152% +$16M 0.01% 954
2025
Q3 		$1.06M Buy
+70,371
New +$871K ﹤0.01% 2400
2024
Q4 		– Sell
-131,422
Closed -$1.51M – 2936
2024
Q3 		$1.51M Sell
131,422
-73,512
-36% -$837K ﹤0.01% 1630
2024
Q2 		$2.17M Sell
204,934
-96,894
-32% -$1.06M ﹤0.01% 1424
2024
Q1 		$3.15M Buy
301,828
+214,884
+247% +$2.32M 0.01% 1210
2023
Q4 		$974K Sell
86,944
-27,665
-24% -$270K ﹤0.01% 1610
2023
Q3 		$1.34M Buy
114,609
+7,489
+7% +$84.7K ﹤0.01% 1489
2023
Q2 		$1.08M Buy
+107,120
New +$958K ﹤0.01% 1521

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management's ROIV Position: Q1 2026 in Review

AQR Capital Management increased its Roivant Sciences (ROIV) stake by 575% in Q1 2026, buying an estimated $130M and bringing the position to 5,946,858 shares worth $162M. The position accounts for 0.07% of the portfolio, ranked #355.

AQR Capital Management first reported a position in ROIV in Q2 2023 and has held it in 9 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • AQR Capital Management held 5,946,858 shares of Roivant Sciences worth $162M as of Q1 2026.
  • AQR Capital Management bought 5,066,085 Roivant Sciences shares in Q1 2026, an estimated $130M.
  • Roivant Sciences made up 0.07% of AQR Capital Management's portfolio in Q1 2026, its #355 holding.
  • AQR Capital Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 9 quarters since.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.